Stem Cell Transplant’s Impact on Relapsed Myeloma
When proteasome inhibitors (like bortezomib) and immunomodulators (like lenalidomide) were introduced in the early 2000s for myeloma therapy, myeloma doctors…
Eclipse Camp 2017 in Rexburg, Idaho, August 19-21, 2017
To date, the Myeloma Crowd Research Initiative has raised $477,000 towards our $500,000 goal. The Myeloma Crowd is hosting Eclipse…
Our Next Show: How Sugar Molecules Act as a Multiple Myeloma Smoke Screen with Michael O’Dwyer, MD, NUI Galway, Friday, August 25 @ 11 am Central
Friday, August 25, 2017 @ 9 am Pacific, 10 am Mountain, 11 am Central, Noon Eastern Call In by Phone…
Full Show: The Latest in Myeloma Therapy Advances with Sagar Lonial, MD, Winship Cancer Institue, Emory University
Sagar Lonial, MD Winship Cancer Institute Interview Date: July 19, 2017 Summary Recent meetings held this summer had important updates…
Our Next Show: How Sugar Molecules Act as a Multiple Myeloma Smoke Screen with Michael O’Dwyer, MD, NUI Galway, Friday, August 25 @ 11 am Central
Friday, August 25, 2017 @ 9 am Pacific, 10 am Mountain, 11 am Central, Noon Eastern Call In by Phone…
Clinical Trial: Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
Daratumumab is a newer immunotherapy approved by the FDA for relapsed myeloma. Because it has few side effects, many researchers…
UPCOMING MYELOMA CROWD ROUNDTABLES
September 30, 2017, Myeloma Crowd Round Tables: New York, NY
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
September 23, 2017, Myeloma Crowd Round Tables: Detroit, Michigan
Myeloma Crowd Round Tables are day-long meetings that provide patients and caregivers updated information so…
MYELOMA CROWD RESEARCH CAMPAIGNS
Myeloma Crowd Research Initiative (MCRI) Funds Two Immunotherapy Projects
The Myeloma Crowd Initiative selected two proposals it has selected for the MCRI crowdsourcing and…
Continuing the Fight for a Myeloma Cure: Dr. Tricot and Dr. Zhan’s Research to Improve Outcomes for High-Risk Myeloma Patients
Guido Tricot, MD, PhD has devotedly attended to thousands of multiple myeloma patients for over…
Thanks to our site sponsors:
